Synentec
Private Company
Funding information not available
Overview
Synentec is a privately held German biotech tools company that has established itself as a specialist in automated, high-performance imaging and laboratory automation for cell-based assays. Its technology platform combines robust hardware like the high-speed CELLAVISTA and the compact NYONE imagers with a comprehensive software ecosystem, including AI-based image analysis and GxP compliance suites. The company serves a broad market in biopharmaceutical R&D, including cell line development, cancer research, stem cell research, immunology, and vaccine development, by providing integrated solutions that enhance throughput and data quality. With nearly two decades of operation, Synentec maintains full vertical integration from development to manufacturing and customer support.
Technology Platform
Integrated hardware-software platform for automated high-throughput cell culture microscopy and image cytometry. Combines microscopes (CELLAVISTA, NYONE) with a comprehensive software ecosystem (YT-SOFTWARE) featuring AI-based analysis, batch processing, automation control, and GxP compliance suites.
Opportunities
Risk Factors
Competitive Landscape
Synentec competes in the automated live-cell imaging and analysis market against major players like Sartorius (Incucyte), Molecular Devices (ImageXpress), Agilent (BioTek), and large microscope manufacturers (Evident/Olympus, Nikon, Leica). Its differentiation lies in high-speed throughput (CELLAVISTA), a fully integrated software suite with AI and GxP features, and a strong focus on application-specific solutions for cell line development.